Vor Biopharma: A Financed Autoimmune Pivot With More Substance Than The Market Realizes

Vor Biopharma pivots to telitacicept for autoimmune diseases, backed by $491M cash to 2029. Click here to read an analysis of ...

Gorman-Rupp: Why This No-Name, Long-Shot Company Is On My Watchlist

My heart wants to Buy. But my head can’t ignore the big valuations following the stocks’ 2026 mega-surge. So for now, I’m at ...
eLife

Continuous developmental changes in word recognition and language learning across early childhood

Analysis of data across many different studies shows that children's word recognition improves continuously from infancy through age 5 years, and shows strong coupling with early vocabulary.
La Brújula Verde

A Bioenergetic Study Places the Col de la Traversette as the Most Probable Route for Hannibal’s Crossing of the Alps

The crossing of the Alps undertaken by the Carthaginian general Hannibal Barca in 218 B.C. with a force of 40,000 soldiers, 7 ...
Investor's Business Daily on MSN

NATO summit centers on F-35 sales, defense deals, spending. Lockheed boosts production

Trump weighs F-35 sale to Turkey as NATO summit commences. NATO details defense deals. Lockheed Martin to boost European ...

Nifty 50

The Nifty is the flagship benchmark of the National Stock Exchange (NSE), which is a well-diversified index, comprising top 50 companies in terms of free-float market ...